Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) traded up 8.6% on Wednesday . The stock traded as high as $45.09 and last traded at $44.97. 711,930 shares traded hands during mid-day trading, a decline of 5% from the average session volume of 751,268 shares. The stock had previously closed at $41.40. Wall […]
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) traded up 8.6% on Wednesday . The stock traded as high as $45.09 and last traded at $44.97. 711,930 shares traded hands during mid-day trading, a decline of 5% from the average session volume of 751,268 shares. The stock had previously closed at $41.40. Wall […]
Avidity Partners Management LP grew its holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 55.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 844,500 shares of the biopharmaceutical company’s stock after acquiring an additional 300,500 shares during the period. […]
Avidity Partners Management LP grew its holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 55.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 844,500 shares of the biopharmaceutical company’s stock after acquiring an additional 300,500 shares during the period. […]
Ultragenyx and Mereo BioPharma Announce New Phase 2 Data globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.